Risk evaluation and monitoring in multiple sclerosis therapeutics.
about
Regulatory T cells in multiple sclerosis and myasthenia gravis.Halo and spillover effect illustrations for selected beneficial medical devices and drugs.Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisTherapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS surveyAlemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis.Multiple sclerosis in men: management considerations.Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.Perception of risk and shared decision making process in multiple sclerosis.Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists - a qualitative study.The tension between early diagnosis and misdiagnosis of multiple sclerosis.The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.
P2860
Q33784969-7AC01C30-C498-4CCF-8615-3071C87A5739Q36133467-D16174AE-05F2-45AB-8233-97D3DBF1B599Q36484448-4C717C59-B826-4712-8EF0-A3BD2E0992EBQ37027674-6C4AED8B-B65E-438A-A148-562B59E67F80Q38262622-1755AA7C-1C3D-4AA7-8751-A51E291EAF7CQ38685411-09329A64-03ED-4607-AC05-4E8ED07CFFDDQ38715565-803C57BE-3733-4A9A-B0CB-B8CF6865C7CFQ38911148-78AA8B07-486F-485E-B5F0-A147CE345EA1Q41526999-3EECB9A9-9482-452E-B68A-5082BD677819Q47800390-5E7906D1-BCC1-4DFB-830E-371C7E499CAEQ53998964-30260836-0CC8-4318-84CC-D1467BA8DE3C
P2860
Risk evaluation and monitoring in multiple sclerosis therapeutics.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@ast
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@en
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@nl
type
label
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@ast
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@en
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@nl
prefLabel
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@ast
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@en
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@nl
P2093
P2860
P356
P1476
Risk evaluation and monitoring in multiple sclerosis therapeutics.
@en
P2093
Jerry S Wolinsky
Michel C Clanet
Raymond J Ashton
Stephen C Reingold
P2860
P304
P356
10.1177/1352458513513207
P5008
P577
2013-11-30T00:00:00Z
2014-09-01T00:00:00Z